[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-497295-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-497295-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ich-harmonised-guideline-e6r3-good-clinical-practice-final-version-adopted-on-06-january-2025","ICH Harmonised Guideline - E6(R3) - Good Clinical Practice - Final version - Adopted on 06 January 2025","","International Council for Harmonisation (ICH) harmonised guideline for Good Clinical Practice, specifically E6(R3) final version. It describes the ICH process context at Step 4, the document history across earlier versions, and the formal legal notice governing copyright and permitted use under acknowledgement requirements. The text includes an ICH consensus structure with an introduction, core GCP principles, and annexes covering governance via IRB/IEC and responsibilities of investigators, including submission, procedures, records, and participant safety and consent.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ich-harmonised-guideline-e6r3-good-clinical-practice-final-version-adopted-on-06-january-2025/497295/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ich-harmonised-guideline-e6r3-good-clinical-practice-final-version-adopted-on-06-january-2025/497295.png","ImageObject",300,407,{"name":42,"@type":43},"McQueen","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-10-02",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the ICH E6(R3) guideline cover?","Question",{"text":63,"@type":64},"It provides the harmonised guideline for Good Clinical Practice, including introduction, principles of ICH GCP, and annex content covering IRB/IEC responsibilities and investigator responsibilities in clinical trials.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the document’s adoption and status information?",{"text":68,"@type":64},"The guideline is the E6(R3) final version, with adoption stated as 06 January 2025.",{"name":70,"@type":61,"acceptedAnswer":71},"What are the key legal notice points regarding use of the document?",{"text":72,"@type":64},"The legal notice states the document is protected by copyright and may be used, reproduced, incorporated, adapted, modified, translated, or distributed under conditions that require acknowledgement, clear labeling of changes, and avoidance of implied ICH endorsement; it is provided “as is” without warranty.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},497295,1791240611,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":108,"slug":109},7,40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},8,"Research & Report",30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":107,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","INTERNATIONAL COUNCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE  \nICH HARMONISED GUIDELINE  \nGUIDELINE FOR GOOD CLINICAL PRACTICE  \nE6(R3)  \nFinal version  \nAdopted on 06 January 2025  \nThis Guideline has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH Process. At Step 4 of the Process the final draft is recommendedfor adoption to the regulatory bodies of ICH regions.  \nE6(R3) Document History  \n\n| Code | History | Date |\n| --- | --- | --- |\n| E6 | Approval by the Steering Committee under Step 2 and release for public consultation. | 27 April 1995 |\n| E6 | Approval by the Steering Committee under Step 4 and recommended for adoption to the three ICH regulatory bodies. | 1 May 1996 |\n| E6(R1) | Approval by the Steering Committee of PostStep 4 editorial corrections. | 10 June 1996 |\n| E6(R2) | Adoption by the Regulatory Members of the ICH Assembly under Step 4. Integrated Addendum to ICH E6(R1) document. Changes are integrated directly into the following sections of the parental Guideline: Introduction, 1.63, 1.64, 1.65, 2. 10, 2. 13, 4.2.5, 4.2.6 , 4.9.0, 5.0, 5.0. 1, 5.0.2, 5.0.3, 5.0.4, 5.0.5, 5.0.6, 5.0.7, 5.2.2, 5.5.3 (a), 5.5.3 (b), 5.5.3 (h), 5.18.3, 5.18.6 (e), 5.18.7, 5.20.1, 8.1 | 9 November 2016 |\n| E6(R3) | Endorsement by the Members of the ICH Assembly under Step 2 and release for public consultation. | 19 May 2023 |\n| E6(R3) | Endorsement by the Regulatory Members of the ICH Assembly under Step 4. | 06 January 2025 |\n\nLegal notice: This document is protected by copyright and may, with the exception of the ICH logo, be used, reproduced, incorporated into other works, adapted, modified, translated or distributed under a public license provided that ICH's copyright in the document is acknowledged at all times. In case of any adaption, modification or translation of the document, reasonable steps must be taken to clearly label, demarcate or otherwise identify that changes were made to or based on the original document. Any impression that the adaption, modification or translation of the original document is endorsed or sponsored by the ICH must be avoided. The document is provided \"as is\" without warranty of any kind. In no event shall the ICH or the authors of the original document be liable for any claim, damages or other liability arising from the use of the document. The above-mentioned permissions do not apply to content supplied by third parties. Therefore, for documents where the copyright vests in a third party, permission for reproduction must be obtained from this copyright holder.  \nICH HARMONISED GUIDELINE  \nGUIDELINE FOR GOOD CLINICAL PRACTICE  \nE6(R3)  \nICH Consensus Guideline  \nTABLE OF CONTENTS  \nI. INTRODUCTION........................................................................................................ 1  \nGuideline Scope ......................................................................................................................... 1  \nGuideline Structure .................................................................................................................... 1  \nII. PRINCIPLES OF ICH GCP.......................................................................................2  \nIII. ANNEX 1 ...................................................................................................................... 7  \n1. INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC) ...........................................................................................7  \n1.1 Submission and Communication ................................................................................... 8  \n1.2 Responsibilities .............................................................................................................. 8  \n1.3 Composition, Functions and Operations ........................................................................9","cbCaieyV2hwGMZBj","https://ap.wps.com/l/cbCaieyV2hwGMZBj","pdf",833486,86,"English","# I. INTRODUCTION\n## Guideline Scope\n## Guideline Structure\n# II. PRINCIPLES OF ICH GCP\n# III. ANNEX 1\n## 1. Institutional Review Board/Independent Ethics Committee (IRB/IEC)\n## 1.1 Submission and Communication\n## 1.2 Responsibilities\n## 1.3 Composition, Functions and Operations\n## 1.4 Procedures\n## 1.5 Records\n## 2. Investigator\n## 2.1 Qualifications and Training\n## 2.2 Resources\n## 2.3 Responsibilities\n## 2.4 Communication with IRB/IEC\n## 2.5 Compliance with Protocol\n## 2.6 Premature Termination or Suspension of a Trial\n## 2.7 Participant Medical Care and Safety Reporting\n## 2.7.1 Medical Care of Trial Participants\n## 2.7.2 Safety Reporting\n## 2.8 Informed Consent of Trial Participants\n## 2.9 End of Participation in a Clinical Trial\n## 2.10 Investigational Product Management\n## 2.11 Randomisation Procedures and Unblinding\n## 2.12 Records","[{\"question\":\"What does the ICH E6(R3) guideline cover?\",\"answer\":\"It provides the harmonised guideline for Good Clinical Practice, including introduction, principles of ICH GCP, and annex content covering IRB/IEC responsibilities and investigator responsibilities in clinical trials.\"},{\"question\":\"What is the document’s adoption and status information?\",\"answer\":\"The guideline is the E6(R3) final version, with adoption stated as 06 January 2025.\"},{\"question\":\"What are the key legal notice points regarding use of the document?\",\"answer\":\"The legal notice states the document is protected by copyright and may be used, reproduced, incorporated, adapted, modified, translated, or distributed under conditions that require acknowledgement, clear labeling of changes, and avoidance of implied ICH endorsement; it is provided “as is” without warranty.\"}]","ICH Harmonised Guideline - E6(R3) - Good Clinical Practice - Final version - Adopted on 06 January 2025 | PDF",1790951313,217]